Security key
05280R100
Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL)
CUSIP: 05280R100
Q2 2019 13F Holders as of 30 Jun 2019
- Type / Class
- Equity / Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share
- Shares outstanding
- 266,837,198
- Total 13F shares
- 21,383,578
- Share change
- +3,283,170
- Total reported value
- $344,232,698
- Price per share
- $16.10
- Number of holders
- 45
- Value change
- +$52,450,982
- Number of buys
- 33
- Number of sells
- 9
Report period
Q2 2019
Institutions
45
Top holders
10
AUTL full security history
Newer quarter: Q3 2019
Previous quarter: Q1 2019
Autolus Therapeutics plc SEC filings
Autolus Therapeutics plc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 05280R100
Recent filing periods:
Top shareholders of AUTL - Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Woodford Investment Management Ltd |
13F
|
Company |
4.5%
|
12,041,419
|
$378,944,000 | — | 31 Mar 2019 | |
| Tetragon Partners GP Ltd |
13F
|
Company |
0.32%
|
851,631
|
$26,801,000 | — | 31 Mar 2019 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.32%
|
850,000
|
$26,750,000 | — | 31 Mar 2019 | |
| Alphabet Inc. |
13F
|
Company |
0.27%
|
714,072
|
$22,472,000 | — | 31 Mar 2019 | |
| Capital World Investors |
13F
|
Company |
0.23%
|
611,112
|
$19,232,000 | — | 31 Mar 2019 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.2%
|
534,517
|
$16,821,000 | — | 31 Mar 2019 | |
| Capital International Investors |
13F
|
Company |
0.18%
|
488,888
|
$15,385,000 | — | 31 Mar 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.17%
|
450,362
|
$14,173,000 | — | 31 Mar 2019 | |
| Artal Group S.A. |
13F
|
Company |
0.17%
|
450,000
|
$14,162,000 | — | 31 Mar 2019 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.09%
|
232,931
|
$7,330,000 | — | 31 Mar 2019 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.07%
|
192,994
|
$6,074,000 | — | 31 Mar 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.07%
|
189,070
|
$5,951,000 | — | 31 Mar 2019 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.06%
|
156,773
|
$4,934,000 | — | 31 Mar 2019 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.03%
|
90,043
|
$2,834,000 | — | 31 Mar 2019 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.02%
|
49,260
|
$1,550,000 | — | 31 Mar 2019 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.02%
|
42,230
|
$1,329,000 | — | 31 Mar 2019 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.01%
|
39,245
|
$1,235,000 | — | 31 Mar 2019 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.01%
|
30,000
|
$944,000 | — | 31 Mar 2019 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0%
|
12,000
|
$378,000 | — | 31 Mar 2019 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0%
|
12,000
|
$378,000 | — | 31 Mar 2019 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0%
|
10,549
|
$332,000 | — | 31 Mar 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
9,811
|
$308,000 | — | 31 Mar 2019 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0%
|
8,720
|
$274,000 | — | 31 Mar 2019 | |
| VIRTUS ADVISERS, LLC |
13F
|
Company |
0%
|
8,434
|
$265,000 | — | 31 Mar 2019 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0%
|
6,362
|
$200,000 | — | 31 Mar 2019 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
3,041
|
$96,000 | — | 31 Mar 2019 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
1,500
|
$47,000 | — | 31 Mar 2019 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
387
|
$12,000 | — | 31 Mar 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
300
|
$9,000 | — | 31 Mar 2019 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
265
|
$8,000 | — | 31 Mar 2019 | |
| Daiwa Securities Group Inc. |
13F
|
Company |
0%
|
115
|
$4,000 | — | 31 Mar 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
92
|
$2,000 | — | 31 Mar 2019 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
46
|
$1,000 | — | 31 Mar 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
42
|
$1,000 | — | 31 Mar 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
27
|
$1,000 | — | 31 Mar 2019 |
Institutional Holders of Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) as of Q2 2019
As of 30 Jun 2019,
Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,383,578 shares.
The largest 10 holders included
Woodford Investment Management Ltd, Capital World Investors, PRICE T ROWE ASSOCIATES INC /MD/, Polygon Management Ltd., MILLENNIUM MANAGEMENT LLC, Cormorant Asset Management, LP, Alphabet Inc., MARSHALL WACE, LLP, Artal Group S.A., and Capital International Investors.
This page lists
45
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2019 vs Q1 2019 Across Filers
Q1 2019 holders
32
Q2 2019 holders
45
Holder diff
13
| Investor | Q1 2019 Shares | Q2 2019 Shares | Share Diff | Share Chg % | Q1 2019 Value $ | Q2 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.